Searched for
RENAL CELL CANCER
One shot could wipe out Cancer bodywide, early trial results leave scientists stunnedCancer treatment single injection results: A redesigned immunotherapy, injected directly into tumors, has shown remarkable results in an ea...- What are MCED tests? Early screening method which can detect around 50 cancers; here’s how they workNew blood tests called MCED tests can detect up to 50 types of cancer from a single draw. These tests are set to revolutionize cancer detec...
- This rock legend diagnosed with stage 4 cancer, fans stunned3 Doors Down lead singer Brad Arnold has revealed his diagnosis of stage 4 clear cell renal carcinoma, which has spread to his lungs. The b...
- Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drugAurobindo Pharma's stock rose after its subsidiary got approval for a cancer drug. CuraTeQ Biologics received the UK's MHRA approval for Be...
- Aurobindo unit gets USFDA nod for generic cancer drugAurobindo Pharma's subsidiary, Eugia Pharma, gets USFDA nod for cancer drug Pazopanib. The drug treats renal cell carcinoma and soft tissue...
- World Kidney Cancer Day: Watch out for early symptoms like unexplained fever, swollen ankles & anaemiaKidney cancer is difficult to diagnose at an early stage as it doesn't come with clear signs. In 2020, around 431,288 new cases of kidney c...
- Biocon Biologics, Viatris receive approval for cancer drugAbevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma,...
- Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to AvastinAbevmy is abiosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cance...
- Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brandIn a regulatory filing, Glenmark Pharma said it launched "SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in I...
- BDR Pharma launches generic cancer drug in IndiaBDR Pharmaceuticals on Wednesday said it has launched the generic version of Lenvatinib drug for the treatment of various types of cancers ...
- US FDA accepts Biocon's cancer drug application for reviewBiocon and Mylan’s proposed biosimilar bevacizumab, a cancer drug, is expected to be the third biosimilar from the partnered portfolio for ...
- Keep weight in check before you hit 40: Obesity can up risk of developing multiple cancersOverweight people had 70% higher chance of developing endometrial cancer and 58% greater risk for renal-cell cancer.
- Medical breakthrough! Aurigene closer to developing cancer treatment capsuleThe Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.
- Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
- Glenmark introduces EMI scheme for cancer treatment drugsAround 12,000 deaths occur due to prostate cancer in the country every year and only about 10-15 per cent patients get complete treatment f...
- World Cancer Day: Why some people fight the disease betterIs it his genes or willpower that some cancer patients respond to medicines more promptly than others? We find out.
- Grilled, barbecued meat may up kidney cancer riskPan-fried, grilled or barbecued meat, cooked at high temperatures or over an open flame, may increase the risk of kidney cancer.
- Natco Pharma's US partner Mylan files application with USFDANatco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly ...
- Rs 110 crore distributed under `Karunya' schemeThe government proposed to extend the 'Karunya' benevolent scheme to more hospitals in the state to help patients suffering from chronic ai...
- Roche files for Avastin to treat breast cancer in EuropeSwiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
Load More
